Turkish registry for diagnosis and treatment of acute heart failure: TAKTIK study

dc.authoridOzcan Celebi, Ozlem/0000-0003-1527-6440
dc.authoridBasarici, Ibrahim/0000-0003-4435-337X
dc.authoridZoghi, Mehdi/0000-0002-8156-2675
dc.authoridDemirbag, Recep/0000-0001-7831-2715
dc.authoridDEVECI, BULENT/0000-0002-9461-3232
dc.authoridOnrat, Ersel/0000-0002-2215-6570
dc.authoridDURSUNOGLU, Prof. Dr. Dursun/0000-0002-5232-7078
dc.contributor.authorEren, Mehmet
dc.contributor.authorZoghi, Mehdi
dc.contributor.authorTuncer, Mustafa
dc.contributor.authorCavusoglu, Yuksel
dc.contributor.authorDemirbag, Recep
dc.contributor.authorSahin, Mahmut
dc.contributor.authorSerdar, Osman Akin
dc.date.accessioned2024-10-26T18:00:03Z
dc.date.available2024-10-26T18:00:03Z
dc.date.issued2016
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractObjective: The goal of this study was to develop a national database of patients hospitalized in Turkey with acute heart failure (AHF) using evaluations of diagnostic and therapeutic approaches. Methods: Patient data were collected using an Internet-based survey. A total of 588 patients were enrolled from 36 participating medical centers across the country. Results: Mean age was 62 +/- 13 years and 38% of the patients were female. Ratio of de novo AHF to study cohort was 24%. Coronary heart disease and hypertension were found in 61% and 53% of the patients, respectively. Valvular heart disease was the underlying cause in 46% of heart failure patients. The most frequent factor associated with decompensation was noncompliance with treatment, observed in 34% of patients. Systolic blood pressure was 125 +/- 28 mmHg and heart rate was 93 +/- 22 beats/minute in the cohort. The most common findings on physical examination were inspiratory fine crackles (84%), peripheral edema (64%), and cold extremities in 34%. Mean ejection fraction (EF) measured at admission was 33 +/- 13%. Preserved EF (>=%40) was present in 20% of patients. On admission, 60%, 46%, and 40% of patients were using angiotens-in-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, or aldosterone antagonist, respectively. In-hospital events were reported as 3.4% death, 1.6% stroke and 2% myocardial infarction. Conclusion: Compared to previous data collected around the world, AHF patients in Turkey were younger, had more frequently valvular heart disease as the underlying cause, and were more noncompliant with medical treatment, but overall mortality was lower. Drugs shown to reduce mortality, and which also form the basis of guideline-directed medical therapy, are still used inadequately.
dc.description.sponsorshipTurkish Society of Cardiology
dc.description.sponsorshipTurkish Society of Cardiology
dc.identifier.doi10.5543/tkda.2016.07572
dc.identifier.endpage646
dc.identifier.issn1016-5169
dc.identifier.issue8
dc.identifier.pmid28045409
dc.identifier.startpage637
dc.identifier.trdizinid240929
dc.identifier.urihttps://doi.org/10.5543/tkda.2016.07572
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/240929
dc.identifier.urihttps://hdl.handle.net/20.500.12418/27485
dc.identifier.volume44
dc.identifier.wosWOS:000392634300003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTurkish Soc Cardiology
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAcute heart failure
dc.subjectInternet
dc.subjectregistry
dc.subjectTurkey
dc.titleTurkish registry for diagnosis and treatment of acute heart failure: TAKTIK study
dc.typeArticle

Dosyalar